Congress trades in Bristol-Myers Squibb Company (BMY)
10 of the members we track disclosed 11 purchases of BMY between 2023-04-10 and 2026-03-27, and 35 sales. Here is what the stock did afterwards.
Every purchase is measured over the three months after the transaction date, against XLV — the ETF standing in for Healthcare & Pharma — over exactly the same dates. The second figure is the one that carries information: the first mostly reflects what the sector did. How BMY was classified.
How these buys are tagged
4 of these purchases were made by a member whose own committee oversees Healthcare & Pharma. 5 are marked Cluster: A buy is marked Cluster when at least one other tracked member of Congress bought the same stock within 30 days of it, regardless of committee membership.
| Buys | Number | Return after 3 months | vs. sector | Beat their sector |
|---|---|---|---|---|
| All buys | 11 | -0.0% | -2.2% | 36% |
| Notable (committee-flagged) | 4 | Too few buys to measure | ||
| Unaligned (no committee overlap) | 7 | +1.2% | +1.6% | 43% |
| Cluster, excl. mega-caps | 5 | -1.4% | -5.1% | 40% |
| Not clustered, excl. mega-caps | 6 | +1.1% | +0.1% | 33% |
Who bought the most
- Gilbert Ray Cisneros, Jr. — 2 buys
- Alan Armstrong — 1 buy
- Julie Johnson — 1 buy
- Virginia Foxx — 1 buy
- Val T. Hoyle — 1 buy
Every disclosed purchase
| Member | Bought disclosed |
Signal | Price | 1W | 1M | 3M | vs sector |
|---|---|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 2026-07-21 |
Notable | $58.54 | +1.8% | +0.3% | -1.7% | -13.7% |
| Gilbert Ray Cisneros, Jr. | 2025-12-19 2026-01-12 |
Unaligned | $54.19 | +0.8% | +2.0% | +6.1% | +12.3% |
| Gilbert Ray Cisneros, Jr. | 2025-11-12 2025-12-15 |
Unaligned | $49.08 | -6.7% | +6.8% | +22.1% | +19.9% |
| Julie Johnson | 2025-01-15 2025-02-12 |
Unaligned | $55.91 | +2.1% | -3.6% | -11.7% | -8.7% |
| Virginia Foxx | 2024-12-06 2025-01-06 |
Unaligned | $59.38 | -6.1% | -4.7% | +2.9% | -0.6% |
| Val T. Hoyle | 2024-10-29 2025-09-12 |
Unaligned Cluster | $52.50 | +6.6% | +12.9% | +11.9% | +13.2% |
| Julia Letlow | 2024-10-23 2026-01-13 |
Notable Cluster | $53.06 | -0.8% | +10.9% | +7.6% | +13.1% |
| John James | 2023-11-10 2024-09-02 |
Notable Cluster | $50.61 | +0.5% | -0.6% | -1.6% | -15.6% |
| Tommy Tuberville | 2023-10-17 2023-11-16 |
Notable Cluster | $57.37 | -2.2% | -11.4% | -12.8% | -19.5% |
| Greg Stanton | 2023-09-26 2023-11-09 |
Unaligned Cluster | $58.54 | -2.3% | -9.5% | -12.1% | -16.4% |
| Dan Goldman | 2023-04-10 2023-05-19 |
Unaligned | $70.28 | +0.5% | -2.5% | -11.1% | -8.5% |
Prices are the closing price on the transaction date, not what was paid: filings never disclose an execution price. Blank figures mean the window has not elapsed yet. Sales are not scored — a sale closes a position rather than opening one — so the 35 disclosed sales of BMY are not in this table.
Download the data behind this page, or read how every figure is calculated. Trades in BMY are a small part of the full rankings, which score each member across everything they bought.
Data last updated .